Nea Management Company, LLC Aveo Pharmaceuticals, Inc. Transaction History

Nea Management Company, LLC

  • $1.4 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.15 - $6.01 $3 - $6
-1 Reduced -0.0%
3,952,957 $22.1 Million
Q2 2020

Aug 05, 2020
BUY
$3.47 - $9.99 $4.96 Million - $14.3 Million
1,428,571 Added 56.59%
3,952,958 $20.4 Million
Q1 2020

May 06, 2020
BUY
$2.6 - $6.9 $6.56 Million - $17.4 Million
2,524,387 New
2,524,387 $9.14 Million

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email